Updates from Neuromod and Lenire
Neuromod Newsroom
Neuromod Appoints Tom Maher as General Counsel
Neuromod Announces Finance Leadership Reorganisation
Neuromod Closes €30 Million Financing
FDA Grants Lenire De Novo Approval
Lenire Now Available in Hungary
Lenire Tinnitus Treatment Device Now Available in Denmark
Nature Scientific Reports Publishes Neuromod Research
Lenire Now Available in Norway
Neuromod Establishes Global Commercial Leadership Team
Stay in the Loop
Register for the Neuromod Newsletter to stay up to date on hearing and tinnitus industry news, emerging tinnitus research, and all things Neuromod and Lenire.
Subscribe
